Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Two more European countries permit phase II studies of resiniferatoxin

July 8, 1999

Uroselective alpha-adrenoceptor blocker GYKI-16084 assessed in BPH and spinal cord injury models

July 7, 1999

Angiotensin II blockade as a strategy for preventing renal allograft nephropathy

July 2, 1999

Nippon Kayaku's new agents for micturition disorders

July 1, 1999

Shire reports positive phase II results for Lambda

June 30, 1999

FDA approves 15-mg Ditropan XL tablets

June 30, 1999

Zeria designs dual-action arylpiperazines for BPH

June 28, 1999

WAY-133537: safe and effective agent for bladder instability

June 28, 1999

Merck describes new selective alpha1a-adrenoceptor blockers and use in BPH

June 21, 1999

Dutasteride suppresses DHT levels more effectively, consistently than finasteride

June 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...